Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Clene Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −3 vs. Q4 2024
- Shares held
- 455.4K
- −35.9K (−7.3%) vs. Q4 2024
- Total value
- $1.40M
- −$1.20M (−46.1%) vs. Q4 2024
- New holders
- 4
- 8 more added
- Sold out
- 7
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.6M |
| Q1 2026 | 29 | $10.8M |
| Q4 2025 | 28 | $11.4M |
| Q3 2025 | 29 | $4.72M |
| Q2 2025 | 24 | $2.28M |
| Q1 2025 | 24 | $1.40M |
| Q4 2024 | 27 | $2.60M |
| Q3 2024 | 20 | $4.66M |
| Q2 2024 | 37 | $2.40M |
| Q1 2024 | 44 | $3.10M |
| Q4 2023 | 46 | $3.50M |
| Q3 2023 | 47 | $12.3M |
| Q2 2023 | 50 | $28.1M |
| Q1 2023 | 31 | $3.42M |
| Q4 2022 | 35 | $3.09M |
| Q3 2022 | 38 | $12.1M |
| Q2 2022 | 42 | $8.93M |
| Q1 2022 | 53 | $24.7M |
| Q4 2021 | 48 | $26.0M |
| Q3 2021 | 39 | $37.8M |
| Q2 2021 | 35 | $51.6M |
| Q1 2021 | 24 | $31.2M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Clene Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 133,334 | $410.7K | 0.00% | +3,714+2.9% | Added |
| Scoggin Management LP | 100,000 | $308.0K | 0.15% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 68,970 | $212.5K | 0.00% | +3,858+5.9% | Added |
| Parsons Capital Management Inc | 36,500 | $112.4K | 0.01% | 00.0% | Unchanged |
| Lunt Capital Management, Inc. | 29,793 | $91.8K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 17,931 | $55.2K | 0.00% | +1,000+5.9% | Added |
| SBI Securities Co., Ltd. | 13,225 | $40.7K | 0.00% | +200+1.5% | Added |
| State Street Corp | 12,501 | $38.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,497 | $35.4K | 0.00% | 00.0% | Unchanged |
| Penn Davis McFarland Inc | 11,000 | $33.9K | 0.00% | +11,000 | New |
| Group One Trading, L.P. | 8,290 | $25.5K | 0.00% | +5,957+255.3% | Added |
| BlackRock, Inc. | 4,171 | $12.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,293 | $7.06K | 0.00% | +1,621+241.2% | Added |
| Atlantic Private Wealth, LLC | 2,205 | $6.79K | 0.01% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 1,682 | $5.18K | 0.00% | −430−20.4% | Reduced |
| Sandy Spring Bank | 1,000 | $3.08K | 0.00% | +1,000 | New |
| Advisor Group Holdings, Inc. | 431 | $1.33K | 0.00% | −614−58.8% | Reduced |
| UBS Group AG | 310 | $955 | 0.00% | +301+3,344.4% | Added |
| MAI Capital Management | 100 | $308 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 100 | $308 | 0.00% | +100 | New |
| Bank of America Corp | 51 | $157 | 0.00% | +5+10.9% | Added |
| US Bancorp | 20 | $62 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 13 | $40 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 7 | $22 | 0.00% | +7 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,835−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −18,040−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −11,547−100.0% | Sold out |
| Fullcircle Wealth LLC | 0 | $0 | 0.00% | −13,023−100.0% | Sold out |
| Washington Trust Co | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |